One more bispecific, humanized IgG1 antibody that is beneath investigation is zenocutuzumab (MCLA-128), which functions by using two independent mechanisms of action: inhibition of HER2–HER3 signalling and elimination of tumour cells by using ADCC. MCLA-128 functions by way of a ‘dock and block’ system whereby a person arm of your https://www.directivepublications.org/journal-of-clinical-breast-cancer/